Loading, please wait...
Date: Aug 25, 2023 09:00 AM - 11:00 AM
CE Hours
2.00
CE Units
0.200
Registration closes on Oct 09, 2023 11:55 PM
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists
- PHARMACY TECHNICIANS
Accreditation(s)
|
The Colegio de Farmacéuticos de Puerto Rico is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Registration Closed
Registration Closed
At the end of the CPE activity the pharmacists should be able to:
- Describe the difference between HIV pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP).
- Recognize which patients are potential candidates for PrEP.
- Identify recommendations by CDC guidelines regarding PrEP management.
- Present an overview of community base PrEP programs or models that have been established in the United States.
- Describe the pharmacy team role in PrEP and HIV transmission prevention efforts.
At the conclusion of the activity, pharmacy technicians should be able to:
- Describe the difference between HIV pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP).
- Recognize which patients are potential candidates for PrEP.
- Present an overview of community base PrEP programs or models that have been established in the United States.
- Describe the pharmacy team role in PrEP and HIV transmission prevention efforts.
Objectives
- At the end of the CPE activity the pharmacists should be able to: Describe the difference between HIV pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP).
- Recognize which patients are potential candidates for PrEP.
- Identify recommendations by CDC guidelines regarding PrEP management.
- Present an overview of community base PrEP programs or models that have been established in the United States.
- Describe the pharmacy team role in PrEP and HIV transmission prevention efforts.
- At the conclusion of the activity, pharmacy technicians should be able to: Describe the difference between HIV pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP).
- Recognize which patients are potential candidates for PrEP.
- Present an overview of community base PrEP programs or models that have been established in the United States.
- Describe the pharmacy team role in PrEP and HIV transmission prevention efforts.
Speaker(s)/Author(s)
|
Kalumi Ayala, Pharm.D., AAHIVP, TTS
|
Activity Number
0151-0000-23-025-L02-P/T
Date:
08/25/23
Time:
09:00 AM - 11:00 AM
CE Hours
2.00
Location
Sheraton Hotel & Casino
Registration Closed